Stocks Comparison
Idexx Laboratories vs Myriad Genetics: revenue, profit, margins and growth compared
Idexx Laboratories brought in $4.3B of revenue in fiscal 2025, Myriad Genetics $824.5M in fiscal 2025. Revenue changed by +10.4% at Idexx Laboratories and -1.6% at Myriad Genetics on the year before, so Idexx Laboratories grew faster. Idexx Laboratories kept 24.6% of its revenue as net profit, Myriad Genetics -44.4%.
Side by side, latest fiscal year
| IDXX | MYGN | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $4.3B | $824.5M |
| Revenue growth | +10.4% | -1.6% |
| Net income | $1.1B | -$365.9M |
| Net margin | 24.6% | -44.4% |
| Free cash flow | $1.1B | n/a |
| Free cash flow margin | 24.6% | n/a |
| Earnings per share (diluted) | $13.08 | -$3.95 |
| Cash | $180.1M | $149.6M |
| Debt | $450M | $119.9M |
| Price to earnings | 39.7 | n/a |
| Market value | $40.9B | $398.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #67 of 523 · Health care | #159 of 523 · Health care |
Over the years
Questions about Idexx Laboratories and Myriad Genetics
Which is bigger by revenue, Idexx Laboratories or Myriad Genetics?
Idexx Laboratories is bigger by revenue: $4.3B in fiscal 2025, against $824.5M for Myriad Genetics in fiscal 2025.
Which keeps more of its revenue as profit, Idexx Laboratories or Myriad Genetics?
Idexx Laboratories had a net margin of 24.6% in fiscal 2025; Myriad Genetics had -44.4% in fiscal 2025.
Which grew revenue faster, Idexx Laboratories or Myriad Genetics?
In their latest fiscal years revenue changed by +10.4% at Idexx Laboratories and -1.6% at Myriad Genetics.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.